Search Results 1591-1600 of 21930 for Inhibition

1. Iga Nephropathy Clinical Trials - Mayo Clinic Research

   ... inhibitors and angiotensin receptor blockers (ARBs). These patients are at high risk for progression of kidney disease, which can result in end-stage renal ...

2. Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - Mayo Clinic

   Previous exposure to other PI3K inhibitors (except copanlisib) is acceptable ... inhibitor. Non-WM patients must have at least one bi-dimensionally ...

3. Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC) - Mayo Clinic

   - Concurrent use of strong inducers or inhibitors of cytochrome P450 (CYP)3A4/5/7. Any strong inhibitor or inducer of CYP3A4/5/7 must be discontinued at ...

4. Fat, Fasting and Multiple Sclerosis - Mayo Clinic News Network

   "These increases in CD38 lead to NAD+ depletion, leaving the myelin-forming oligodendrocytes vulnerable to degeneration. Restoring NAD+ via CD38 inhibition ...

5. Publications - Chris L. Hallemeier, M.D. - Mayo Clinic

   ... Inhibitors-Preclinical Evidence. Cancers (Basel). 2026 Feb 19; 18 (4) View PubMed; Salazar-Vilches CJ, Ebner DK, Kloeber JA, Dragojevic S, Singh J, Haddock M ...

6. A Study To Investigate The Efficacy And Safety Of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib In Adults With Relapsed/Refractory Mantle Cell Lymphoma - Mayo Clinic

   * Prior therapy with B-cell lymphoma-2 inhibitor * Prior therapy with covalent or non-covalent Bruton tyrosine kinase inhibitor (BTKi) unless the ...

7. Escalating Dose Study in Subjects with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia - Mayo Clinic

   Prior treatment with a Btk inhibitor; Active uncontrolled infection; History ... Based on the success of CC-292 and other inhibitors of the BCR pathway ...

8. A Phase 1/2 Study to Evaluate MEDI4736 - Clinical Trials

   ... inhibitors or natural killer (NK) cell inhibitors. Active or prior documented autoimmune disease within the past 2 years; History of primary immunodeficiency ...

9. A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma - Mayo Clinic

   ... inhibitor. Additional Inclusion Criteria for Cohort B2 (R/R FL or MZL): ... inhibitors, which cannot be discontinued within 5 half-lives of the first ...

10. SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Have received prior therapy with an immunomodulatory agent, a proteosome inhibitor, and glucocorticoids ... inhibitors; or are receiving treatment with agents ...